Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo

Journal of the American College of Cardiology

Volumn 35, Issue 4, 2000, Pages 1040-1047

  Morishige, Kunio ^a   Shimokawa, Hiroaki ^a   Yamawaki, Tohru ^a   Miyata, Kenji ^a   Eto, Yasuhiro ^a   Kandabashi, Tadashi ^a   Yogo, Kenji ^a   Higo, Taiki ^a   Egashira, Kensuke ^a   Ueno, Hikaru ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CYCLIC GMP; NATRIURETIC PEPTIDE TYPE C;

ADENOVIRUS; ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ANOMALY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; SWINE; TRANSLUMINAL CORONARY ANGIOPLASTY; TUNICA MEDIA;

ADENOVIRIDAE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY DISEASE; CORONARY VESSELS; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; NATRIURETIC PEPTIDE, C-TYPE; RECURRENCE; SWINE;

EID: 19244382718     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00625-7     Document Type: Article

References (41)

1. Popma J.J., Topol E.J. Factors influencing restenosis after coronary angioplasty. Am J Med. 88:1990;16N-24N.
2. Currier J.W., Faxon D.P. Restenosis after percutaneous transluminal coronary angioplasty have we been aiming at the wrong target? J Am Coll Cardiol. 25:1995;516-520.
3. Post M.J., Borst C., Kuntz R.E. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation. 89:1994;2816-2821.
4. Lafont A., Guzman L.A., Whitlow P.L., et al. Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res. 76:1995;996-1002.
5. Andersen H.R., Maeng M., Thorwest M., Falk E. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury insights from a porcine coronary (re)stenosis model. Circulation. 93:1996;1716-1724.
6. Strauss B.H., Chisholm R.J., Keeley F.W., et al. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res. 75:1994;650-658.
7. Nabel E.G., Plautz G., Nabel G.J. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science. 249:1990;1285-1288.
8. Chang M.W., Barr E., Seltzer J., et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 267:1995;518-522.
9. Ueno H., Yamamoto H., Ito S., Li J.J., Takeshita A. Adenovirus-mediated transfer of a dominant-negative H-ras suppresses neointimal formation in balloon-injured arteries in vivo. Arterioscler Thromb Vasc Biol. 17:1997;898-904.
10. Ueno H., Masuda S., Nishio S., et al. Adenovirus-mediated transfer of cyclin-dependent kinase inhibitor-p21 suppresses neointimal formation in the balloon-injured rat carotid arteries in vivo. Ann NY Acad Sci. 811:1997;401-411.
11. Ueno H., Haruno A., Morisaki N., et al. Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop. Circulation. 96:1997;2272-2279.
12. Muller D.W., Ellis S.G., Topol E.J. Experimental models of coronary artery restenosis. J Am Coll Cardiol. 19:1992;418-432.
13. Karas S.P., Gravanis M.B., Santoian E.C., et al. Coronary intimal proliferation after balloon injury and stenting in swine an animal model of restenosis. J Am Coll Cardiol. 20:1992;467-474.
14. Komatsu Y., Nakao K., Suga S., et al. C-type natriuretic peptide (CNP) in rats and humans. Endocrinology. 129:1991;1104-1106.
15. Ogawa Y., Nakao K., Nakagawa O., et al. Human C-type natriuretic peptide. Characterization of the gene and peptide. Hypertension. 19:1992;809-813.
16. Barletta G., Lazzeri C., Vecchiarino S., et al. Low-dose C-type natriuretic peptide does not affect cardiac and renal function in humans. Hypertension. 31:1998;802-808.
17. Itoh H., Suga S., Ogawa Y., et al. Significance of vascular natriuretic peptide system in vascular remodeling in humans and its application to gene therapy. Ann New York Acad Sci. 811:1997;533-541.
18. Wei C.M., Aarhus L.L., Miller V.M., Burnett J.C. Jr. Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol. 264:1993;H71-H73.
19. Wei C.M., Hu S., Miller V.M., Burnett J.C. Jr. Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells. Biochem Biophys Res Commun. 205:1994;765-771.
20. Doi K., Itoh H., Ikeda T., et al. Adenovirus-mediated gene transfer of C-type natriuretic peptide causes G1 growth inhibition of cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 239:1997;889-894.
21. Ikeda M., Kohno M., Yasunari K., et al. Natriuretic peptide family as a novel antimigration factor of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 17:1997;731-736.
22. Naruko T., Ueda M., van der Wal A.C., et al. C-type natriuretic peptide in human coronary atherosclerotic lesions. Circulation. 94:1996;3103-3108.
23. Koller K.J., Lowe D.G., Bennett G.L., et al. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 252:1991;120-123.
24. Garg U.C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 83:1989;1774-1777.
25. Marumo T., Nakaki T., Hishikawa K., et al. Natriuretic peptide-augmented induction of nitric oxide synthase through cyclic guanosine 3',5'-monophosphate elevation in vascular smooth muscle cells. Endocrinology. 136:1995;2135-2142.
26. Barath P., Popov A., Dillehay G.L., Matos G., McKiernan T. Infiltrator angioplasty balloon catheter a device for combined angioplasty and intramural site-specific treatment. Cathet Cardiovasc Diagn. 41:1997;333-341.
27. Pavlides G.S., Barath P., Maginas A., et al. Intramural drug delivery by direct injection within the arterial wall first clinical experience with a novel intracoronary delivery infiltrator system. Cathet Cardiovasc Diagn. 41:1997;287-292.
28. Ueno H., Li J.J., Tomita H., et al. Quantitative analysis of repeat adenovirus-mediated gene transfer into injured canine femoral arteries. Arterioscler Thromb Vasc Biol. 15:1995;2246-2253.
29. Kojima M., Minamino N., Kangawa K., Matsuo H. Cloning and sequence analysis of a cDNA encoding a precursor for rat C-type natriuretic peptide (CNP). FEBS Lett. 276:1990;209-213.
30. Tawaragi Y., Fuchimura K., Tanaka S., et al. Gene and precursor structures of human C-type natriuretic peptide. Biochem Biophys Res Commun. 175:1991;645-651.
31. Sudoh T., Minamino N., Kangawa K., Matsuo H. C-type natriuretic peptide (CNP) a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun. 168:1990;863-870.
32. Fukumoto Y., Shimokawa H., Kozai T., et al. Tyrosine kinase inhibitor suppresses the (re)stenotic changes of the coronary artery after balloon injury in pigs. Cardiovasc Res. 32:1996;1131-1140.
33. Yamawaki T., Shimokawa H., Kozai T., et al. Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo. J Am Coll Cardiol. 32:1998;273-279.
34. Espiner E.A. Physiology of natriuretic peptides. J Intern Med. 235:1994;527-541.
35. Brandt R.R., Mattingly M.T., Clavell A.L., Barclay P.L., Burnett J.C. Jr. Neutral endopeptidase regulates C-type natriuretic peptide metabolism but does not potentiate its bioactivity in vivo. Hypertension. 30:1997;184-190.
36. Varenne O., Pislaru S., Gillijns H., et al. Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation. 98:1998;919-926.
37. Ohashi Y., Kawashima S., Hirata K., et al. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest. 102:1998;2061-2071.
38. Kozai T., Shimokawa H., Fukumoto Y., et al. Tyrosine kinase inhibitor markedly suppresses the development of coronary lesions induced by chronic treatment with platelet-derived growth factor in pigs in vivo. J Cardiovasc Pharmacol. 295:1997;536-545.
39. French B.A., Mazur W., Ali N.M., et al. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atheroscle-rotic arteries, and two models of coronary restenosis. Circulation. 90:1994;2402-2413.
40. Chapman G.D., Lim C.S., Gammon R.S., et al. Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter. Circ Res. 71:1992;27-33.
41. Kullo I.J., Simari R.D., Schwartz R.S. Vascular gene therapy. From bench to bedside. Arterioscler Throm Vasc Biol. 19:1999;196-207.